Trial Profile

A randomized, open-label trial of telbivudine versus adefovir dipivoxil in adults With HBegAg [Hepatitis B e antigen]-positive, compensated chronic hepatitis B

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 15 May 2015

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Telbivudine (Primary) ; Adefovir dipivoxil
Indications Hepatitis B
Focus Adverse reactions; Therapeutic Use
Sponsors Idenix Pharmaceuticals; Merck Sharp & Dohme

Most Recent Events

04 Dec 2007 Results have been published
24 May 2007 Interim results have been reported at DDW.
11 Dec 2006 Status change

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com